IDXX IDEXX LABORATORIES INC

2026Q2 · CUSIP 45168D104 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it

1,259

Institutions that reported holding it to the SEC

Net decrease in holders

Last quarter 1,301 → now 1,259

How unusual is that

Bottom 20%

Stronger than only 3% of US stocks

What the filings say, in one paragraph

1,259 funds held IDXX at the end of 2026Q2, down 42 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $4.6B(YoY +12.8%), the P/E is 37.9x, return on equity is 70.7%. IDXX has had 32 buying rushes in its history, and the price moved +8.2% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

What happened after each past buying rush 32 times in its history

Quarter of the rush	How unusual then	Price, next 3 months	Price, next 6 months
2025Q4	Top 5%	-12.2%	—
2025Q3	Top 5%	-5.7%	-17.3%
2025Q2	Top 5%	+8.2%	-0.5%
2025Q1	Top 20%	+22.0%	+28.2%
2023Q4	Top 5%	-2.2%	-10.5%
2023Q2	Top 20%	-9.1%	+13.9%
2023Q1	Top 5%	-0.1%	-5.5%
2022Q4	Top 5%	-2.8%	-4.5%
2021Q4	Top 10%	-29.7%	-26.2%
2021Q3	Top 5%	-21.4%	-41.9%
2021Q2	Top 20%	-6.5%	-25.0%
2021Q1	Top 10%	+28.2%	+19.9%
2020Q4	Top 5%	-4.3%	+22.7%
2020Q3	Top 5%	+20.9%	+21.5%
2020Q2	Top 10%	+18.0%	+40.6%
2019Q4	Top 20%	+1.9%	+31.4%
2019Q2	Top 5%	-6.6%	+4.1%
2018Q3	Top 5%	+2.3%	+24.3%
2018Q2	Top 20%	-19.1%	-13.1%
2018Q1	Top 5%	+24.4%	+0.6%
2017Q4	Top 20%	+10.0%	+33.4%
2017Q2	Top 5%	-3.7%	+16.9%
2017Q1	Top 10%	-3.6%	-7.1%
2016Q4	Top 10%	+13.8%	+7.0%
2016Q3	Top 5%	+26.1%	+43.4%
2016Q2	Top 5%	+2.1%	+28.1%
2016Q1	Top 5%	+25.5%	+28.0%
2015Q3	Top 20%	+4.5%	+30.1%
2014Q4	Top 10%	-12.4%	-0.1%
2014Q3	Top 10%	+4.8%	-8.2%
2014Q1	Top 20%	-0.3%	+17.6%
2013Q4	Top 20%	+2.5%	+1.9%

Show all 32 events

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾

Of them, large funds

350

Change in large funds

+24

Total value they hold

$38.6B

Funds buying for the first time

117

Funds that sold out entirely

159

Price change that quarter

-1.2%

Funds holding puts (bearish)

Funds holding calls (bullish)

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)

37.9

EPS (TTM)

$14.23

EPS YoY

+18.5%

Revenue (TTM)

$4.6B

Revenue YoY

+12.8%

Net margin

25.0%

ROE

70.7%

Debt ratio

53.1%

FCF (TTM)

$1.3B

Dividend (TTM)

No dividend

Quarterly Revenue & EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow

Latest quarter $234M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.